Literature DB >> 27426942

Identification of biofilms in post-tympanostomy tube otorrhea.

Winslo K Idicula1,2, Joseph A Jurcisek3, Nathan D Cass4, Syed Ali4, Steven D Goodman3, Charles A Elmaraghy1,2, Kris R Jatana1,2, Lauren O Bakaletz3.   

Abstract

OBJECTIVES/HYPOTHESIS: Otitis media is a common problem in the pediatric population. Despite antibiotic therapy, post-tympanostomy otorrhea can be difficult to treat. Biofilms have been shown to play a role in chronic and recurrent otitis media and are implicated in otorrhea. This study investigated both the microbial composition and the presence of biofilm fragments rich in extracellular DNA (eDNA) and the bacterial DNA-binding protein, integration host factor (IHF), in post-tympanostomy tube otorrhea. STUDY
DESIGN: Clinical samples.
METHODS: Institutional review board approval was obtained, and samples were recovered from pediatric patients with tympanostomy tubes and persistent otorrhea for both microbial culture and biofilm analysis. For biofilm assessment, frozen samples were sectioned and then labeled using a rabbit anti-IHF, which was detected with goat anti-rabbit IgG conjugated to AlexaFluor 594. Samples were then counterstained with 4',6-diamidino-2-phenylindole (DAPI) to detect DNA, and images were captured by inverted light microscopy.
RESULTS: Of 15 pediatric otorrhea samples analyzed, nine (60%) contained solids that were positive for labeling of IHF in association with a lattice of eDNA, and 75% yielded positive bacterial cultures. Bacterial culture results included H. influenzae, Methicillin-resistant Staphylococcus aureus, S. pneumoniae, M. catarrhalis, and P. aeruginosa.
CONCLUSION: Positive labeling of otorrhea solids for eDNA and IHF, in combination with microbiological culture results, indicated that biofilms likely played a key role in chronic otorrhea. Moreover, as a known critical structural component of biofilms, these findings suggest that DNABII proteins in association with eDNA may serve as an important therapeutic target in post-tympanostomy tube otorrhea. LEVEL OF EVIDENCE: NA. Laryngoscope, 126:1946-1951, 2016.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Post-tympanostomy tube otorrhea; acute otitis media; anti-IHF; biofilms; chronic otitis media with effusion; tympanostomy tube

Mesh:

Substances:

Year:  2016        PMID: 27426942      PMCID: PMC4955598          DOI: 10.1002/lary.25826

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  33 in total

1.  Extracellular DNA required for bacterial biofilm formation.

Authors:  Cynthia B Whitchurch; Tim Tolker-Nielsen; Paula C Ragas; John S Mattick
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

2.  In vivo resistance to bacterial biofilm formation on tympanostomy tubes as a function of tube material.

Authors:  I S Saidi; J F Biedlingmaier; P Whelan
Journal:  Otolaryngol Head Neck Surg       Date:  1999-05       Impact factor: 3.497

Review 3.  The role of biofilms in otolaryngologic infections.

Authors:  J Christopher Post; Paul Stoodley; Luanne Hall-Stoodley; Garth D Ehrlich
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-06       Impact factor: 2.064

4.  Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins.

Authors:  S D Goodman; K P Obergfell; J A Jurcisek; L A Novotny; J S Downey; E A Ayala; N Tjokro; B Li; S S Justice; L O Bakaletz
Journal:  Mucosal Immunol       Date:  2011-06-29       Impact factor: 7.313

5.  Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.

Authors:  Joseph Dohar; William Giles; Peter Roland; Nadim Bikhazi; Sean Carroll; Roderick Moe; Bradley Reese; Sheryl Dupre; Michael Wall; David Stroman; Celeste McLean; Krista Crenshaw
Journal:  Pediatrics       Date:  2006-07-31       Impact factor: 7.124

Review 6.  Otitis media in children: frequency, risk factors, and research avenues.

Authors:  C Infante-Rivard; A Fernández
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

7.  Tympanostomy tubes: experience with removal.

Authors:  M J Cunningham; R D Eavey; J H Krouse; R M Kiskaddon
Journal:  Laryngoscope       Date:  1993-06       Impact factor: 3.325

8.  Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes.

Authors:  E L Goldblatt; J Dohar; R J Nozza; R W Nielsen; T Goldberg; J D Sidman; M Seidlin
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1998-11-15       Impact factor: 1.675

9.  Ambulatory surgery in the United States, 2006.

Authors:  Karen A Cullen; Margaret J Hall; Aleksandr Golosinskiy
Journal:  Natl Health Stat Report       Date:  2009-01-28

10.  Development of a novel biodegradable drug-eluting ventilation tube for chronic otitis media with effusion.

Authors:  Chee Wee Gan; Wai Hon Chooi; Herr Cheun Anthony Ng; Yee Shan Wong; Subbu S Venkatraman; Lynne Hsueh Yee Lim
Journal:  Laryngoscope       Date:  2013-05-10       Impact factor: 3.325

View more
  22 in total

1.  The extracellular DNA lattice of bacterial biofilms is structurally related to Holliday junction recombination intermediates.

Authors:  Aishwarya Devaraj; John R Buzzo; Lauren Mashburn-Warren; Erin S Gloag; Laura A Novotny; Paul Stoodley; Lauren O Bakaletz; Steven D Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

2.  Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery.

Authors:  Joseph A Jurcisek; Kenneth L Brockman; Laura A Novotny; Steven D Goodman; Lauren O Bakaletz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

Review 3.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

4.  Identification of essential biofilm proteins in middle ear fluids of otitis media with effusion patients.

Authors:  Christine L Barron; Louie B Kamel-Abusalha; Rishabh Sethia; Steven D Goodman; Charles A Elmaraghy; Lauren O Bakaletz
Journal:  Laryngoscope       Date:  2019-04-25       Impact factor: 3.325

5.  Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae.

Authors:  Laura A Novotny; Kenneth L Brockman; Elaine M Mokrzan; Joseph A Jurcisek; Lauren O Bakaletz
Journal:  J Pediatr Infect Dis       Date:  2018-07-06       Impact factor: 0.293

Review 6.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

7.  Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms.

Authors:  Lauren Martyn; Rishabh Sethia; Rachel Chon; Laura Novotny; Steven D Goodman; Charles Elmaraghy; Lauren O Bakaletz
Journal:  Laryngoscope       Date:  2019-07-17       Impact factor: 3.325

8.  A bacterial-biofilm-induced oral osteolytic infection can be successfully treated by immuno-targeting an extracellular nucleoid-associated protein.

Authors:  M O Freire; A Devaraj; A Young; J B Navarro; J S Downey; C Chen; L O Bakaletz; H H Zadeh; S D Goodman
Journal:  Mol Oral Microbiol       Date:  2016-04-05       Impact factor: 3.563

Review 9.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

10.  Humanized Anti-DNABII Fab Fragments Plus Ofloxacin Eradicated Biofilms in Experimental Otitis Media.

Authors:  Laura A Novotny; Tendy Chiang; Steven D Goodman; Charles A Elmaraghy; Lauren O Bakaletz
Journal:  Laryngoscope       Date:  2021-03-05       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.